ERTS Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Hold
318
0.11% 26
2026
Q1
$292K Hold
318
0.09% 27
2025
Q4
$342K Hold
318
0.11% 26
2025
Q3
$243K Hold
318
0.08% 27
2025
Q2
$248K Hold
318
0.09% 26
2025
Q1
$263K Hold
318
0.05% 73
2024
Q4
$245K Hold
318
0.05% 81
2024
Q3
$282K Hold
318
0.05% 82
2024
Q2
$288K Hold
318
0.06% 76
2024
Q1
$247K Buy
+318
New +$226K 0.05% 83
2019
Q1
Sell
-29
Closed -$3K 214
2018
Q4
$3K Buy
+29
New +$3.24K ﹤0.01% 288

Other funds holding LLY

ERTS Wealth Advisors's LLY Position: Q2 2026 in Review

ERTS Wealth Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 318 shares worth $381K. The position accounts for 0.11% of the portfolio, ranked #26.

ERTS Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ERTS Wealth Advisors held 318 shares of Eli Lilly worth $381K as of Q2 2026.
  • ERTS Wealth Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.11% of ERTS Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • ERTS Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ERTS Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.